Drug class
Kinase Inhibitor
20 drugs the FDA files under Kinase Inhibitor, and that we can price. Drugs in one class are not interchangeable — they share a mechanism, not a dose or a set of side effects — but the price gap between them is often large, and it is a reasonable thing to raise with a prescriber.
- bosutinib 400 MG Oral TabletKinase Inhibitor
- erlotinib 100 MG Oral TabletKinase Inhibitor
- erlotinib 150 MG Oral TabletKinase Inhibitor
- erlotinib 25 MG Oral TabletKinase Inhibitor
- everolimus 0.25 MG Oral TabletKinase Inhibitor
- everolimus 0.5 MG Oral TabletKinase Inhibitor
- everolimus 0.75 MG Oral TabletKinase Inhibitor
- everolimus 1 MG Oral TabletKinase Inhibitor
- everolimus 10 MG Oral TabletKinase Inhibitor
- everolimus 2 MG Tablet for Oral SuspensionKinase Inhibitor
- everolimus 2.5 MG Oral TabletKinase Inhibitor
- everolimus 5 MG Oral TabletKinase Inhibitor
- everolimus 7.5 MG Oral TabletKinase Inhibitor
- gefitinib 250 MG Oral TabletKinase Inhibitor
- nilotinib 150 MG Oral CapsuleKinase Inhibitor
- nilotinib 200 MG Oral CapsuleKinase Inhibitor
- nilotinib 50 MG Oral CapsuleKinase Inhibitor
- pazopanib 200 MG Oral TabletKinase Inhibitor
- remibrutinib 25 MG Oral Tablet [Rhapsido]Kinase Inhibitor
- sorafenib 200 MG Oral TabletKinase Inhibitor